Why the study?
What is the annual incidence of failure for Endotak Reliance, Sprint Quattro, and Durata transvenous ICD leads?
What is the annual incidence of failure for Endotak Reliance, Sprint Quattro, and Durata transvenous ICD leads?
Answers are grounded in this paper and cite their sources.
Endotak Reliance, Sprint Quattro, and Durata ICD leads demonstrate low annual failure rates, but long-term safety data remain limited.
Endotak Reliance (8F), Sprint Quattro (8F), and Durata (7F) leads displayed low annual incidence of failure; however, long-term follow-up data are still scarce. More data are needed to clarify the performance and safety of the Durata lead.
No takes yet. Share an insight, caveat, or question.
Providência et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: